Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Geratherm Medical AGXTER:GME +2.75%72 Gross Margin % is 68.50% as of Dec. 2025, which is 4% above its 10-year median of 65.97. GuruFocus rates XTER:GME with a GF Score™ of 72/100 and a GF Value™ of €3.16 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Geratherm Medical AG ranks better than 71.8% on this metric.
Geratherm Medical AG gross margin has been in long-term decline. The average rate of decline per year is -2.2%.
The historical rank and industry rank for Geratherm Medical AG's Gross Margin % or its related term are showing as below:
XTER:GME'
s Gross Margin % Range Over the Past 10 Years
Min: 46.99 Med: 65.97 Max: 79.99
Current: 65.69
During the past 13 years, the highestGross Margin % of Geratherm Medical AG was 79.99%. The lowest was 46.99%. And the median was 65.97%.
XTER:GME's Gross Margin % is ranked better than 71.8% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs XTER:GME: 65.69
Geratherm Medical AG had a gross margin of 68.50% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Geratherm Medical AG was -2.20% per year.
Geratherm Medical AG (XTER:GME) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Geratherm Medical AG had a gross margin of 68.50% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Geratherm Medical AG Gross Margin % Related Terms
Geratherm Medical AG Gross Margin % Historical Data
* Premium members only.
The historical data trend for Geratherm Medical AG's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:GME vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Geratherm Medical AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Geratherm Medical AG Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Geratherm Medical AG's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Geratherm Medical AG (XTER:GME) has a Gross Margin % of 68.50% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Geratherm Medical AG and its competitors. This is near median its historical median of 65.97. Over the past decade, Geratherm Medical AG's Gross Margin % has ranged from 46.99 to 79.99. According to the industry distribution chart, Geratherm Medical AG ranks #227 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 28.2%.
Is Geratherm Medical AG's Gross Margin % too high?
Geratherm Medical AG's current Gross Margin % of 68.50% is near median its 10-year median of 65.97. Over the past 10 years, this metric has ranged from a low of 46.99 to a high of 79.99. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Geratherm Medical AG's value of 68.50% is 31.6% above this industry median. Based on the distribution chart, Geratherm Medical AG ranks #227 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Geratherm Medical AG has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Geratherm Medical AG's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Geratherm Medical AG ranks #227 out of 805 companies for Gross Margin %. This puts Geratherm Medical AG in the upper half of its industry. The industry median Gross Margin % is 52.07. Geratherm Medical AG's value of 68.50% is 31.6% above this benchmark. Historically, Geratherm Medical AG's own Gross Margin % has ranged from 46.99 to 79.99 over the past decade. While the company's 10-year median is 65.97 vs. the industry median of 52.07, Geratherm Medical AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Geratherm Medical AG's current Gross Margin % of 68.50% is 31.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Geratherm Medical AG and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Geratherm Medical AG's current Gross Margin % is 68.50%, which is near median its own 10-year median of 65.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Geratherm Medical AG stock overvalued right now?
Based on GuruFocus' analysis, Geratherm Medical AG (XTER:GME) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.16, compared to a current price of €2.62 — trading 17.1% below its estimated fair value. The current Gross Margin % is 68.50%, which is near median its 10-year median of 65.97 and 31.6% above the Medical Devices & Instruments industry median of 52.07. Geratherm Medical AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Geratherm Medical AG (XTER:GME), the current Gross Margin % is 68.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Geratherm Medical AG (XTER:GME) Overvalued in 2026?
Based on GuruFocus' analysis, Geratherm Medical AG stock appears to be undervalued.
The current stock price of €2.62 is trading 17.1% below its estimated GF Value™ of €3.16.
GuruFocus considers Geratherm Medical AG to be Modestly Undervalued.
Key valuation signals for XTER:GME:
Gross Margin %: 68.50% (near median its 10-year median of 65.97)
GF Value™: €3.16 vs. price of €2.62 (17.1% below fair value)
Industry Position: 31.6% above the Medical Devices & Instruments median (#227 of 805)
No single metric tells the full story. See the XTER:GME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
72GF Score
Get the complete analysis for XTER:GME
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:GME has been successfully added to your 
